News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pfizer Japan Inc. Obtains Manufacturing Approval Of Gabapentin For Antiepileptic
August 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Pfizer Japan Inc. has obtained manufacturing approval of Gabapentin on July 26. Gabapentin can be taken in conjunction with other drugs. Since it does not induce drug-metabolizing enzymes, it has proven to be safely taken with other drugs.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
September 11, 2025
·
2 min read
·
Dan Samorodnitsky
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
·
2 min read
·
Tristan Manalac
Podcast
Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change
August 27, 2025
·
1 min read
·
Jef Akst
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
August 27, 2025
·
2 min read
·
Annalee Armstrong